Xenetic is a leading UK based biopharmaceutical company providing leading edge expertise in the development of a whole new generation of drugs and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas. We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen and ImuXen platform technologies.

Acquired Companies: SymbioTec GmbH